生物标志物GDF-15、NTproBNP和hs-TnT对2型糖尿病合并肾病患者发病和死亡的预测特性
本研究为对Sun-MACRO试验的事后分析,纳入861例2型糖尿病合并肾病患者,评估基线血清GDF-15、NTproBNP和hs-TnT与肾脏及心血管事件的关联。多因素回归显示GDF-15、NTproBNP和hs-TnT与肾脏事件独立相关,NTproBNP与心血管事件独立相关;在肾脏模型中加入NTproBNP和hs-TnT可改善C统计量(0.793 vs 0.741,P=0.04),在心血管模型中加入NTproBNP可改善C统计量(0.722 vs 0.658,P=0.018)。
要点
- GDF-15(HR 1.83,P=0.04)、NTproBNP(HR 2.34,P=0.004)和hs-TnT(HR 2.09,P=0.014)与肾脏事件独立相关。
- NTproBNP(HR 3.45,P<0.001)与心血管事件独立相关。
- 肾脏模型加入NTproBNP和hs-TnT后C统计量由0.741升至0.793(P=0.04);心血管模型加入NTproBNP后C统计量由0.658升至0.722(P=0.018)。
核心结论
- 生物标志物GDF-15、NTproBNP和hs-TnT与肾脏风险独立相关,而NTproBNP独立预测心血管风险。
研究设计与样本
- 对sulodexide宏白蛋白尿(Sun-MACRO)试验的事后分析,纳入861例2型糖尿病合并肾病患者,采用Cox多因素回归和C统计量分析基线血清GDF-15、NTproBNP和hs-TnT与肾脏及心血管事件的前瞻性关联。
- 肾脏基础模型包括白蛋白与肌酐比值(ACR)、血清肌酐、血红蛋白、年龄和性别;心血管基础模型包括舒张压、ACR、胆固醇、年龄和性别。
主要发现
- 平均(±SD)估算肾小球滤过率为33±9 mL/min/1.73 m²;GDF-15中位血清浓度为3,228 pg/mL(四分位距2,345-4,310 pg/mL),NTproBNP为380 ng/L(155-989 ng/L),hs-TnT为30 ng/L(20-47 ng/L)。
- 多因素回归分析中,GDF-15(HR 1.83,P=0.04)、NTproBNP(HR 2.34,P=0.004)和hs-TnT(HR 2.09,P=0.014)与肾脏事件相关,NTproBNP(HR 3.45,P<0.001)与心血管事件相关。
- 在肾脏模型中加入NTproBNP和hs-TnT后C统计量改善(0.793 vs 0.741,P=0.04);在心血管模型中仅加入NTproBNP后C统计量改善(0.722 vs 0.658,P=0.018)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although patients with type 2 diabetes (T2D) with nephropathy are at high risk for renal and cardiovascular complications, relevant biomarkers have been poorly identified. Because renal impairment may increase biomarker levels, this potentially confounds associations between biomarker levels and risk. To investigate the predictive value of a biomarker in such a setting, we examined baseline levels of growth differentiation factor-15 (GDF-15), N-terminal prohormone of B-type natriuretic peptide (NTproBNP), and high-sensitivity troponin T (hs-TnT) in relation to renal and cardiovascular risk in T2D patients with nephropathy. RESEARCH DESIGN AND METHODS: Eight hundred sixty-one T2D patients from the sulodexide macroalbuminuria (Sun-MACRO) trial were included in our post hoc analysis. Prospective associations of baseline serum GDF-15, NTproBNP, and hs-TnT with renal and cardiovascular events were determined by Cox multiple regression and C-statistic analysis. Renal base models included albumin-to-creatinine ratio (ACR), serum creatinine, hemoglobin, age, and sex. Cardiovascular base models included diastolic blood pressure, ACR, cholesterol, age, and sex. RESULTS: The mean (±SD) estimated glomerular filtration rate was 33 ± 9 mL/min/1.73 m2, and the median serum concentration for GDF-15 was 3,228 pg/mL (interquartile range 2,345-4,310 pg/mL), for NTproBNP was 380 ng/L (155-989 ng/L), and for hs-TnT was 30 ng/L (20-47 ng/L). In multiple regression analysis, GDF-15 (hazard ratio [HR] 1.83, P = 0.04), NTproBNP (HR 2.34, P = 0.004), and hs-TnT (HR 2.09, P = 0.014) were associated with renal events, whereas NTproBNP (HR 3.45, P < 0.001) was associated with cardiovascular events. The C-statistic was improved by adding NTproBNP and hs-TNT to the renal model (0.793 vs. 0.741, P = 0.04). For cardiovascular events, the C-statistic was improved by adding NTproBNP alone (0.722 vs. 0.658, P = 0.018). CONCLUSIONS: Biomarkers GDF-15, NTproBNP, and hs-TnT associate independently with renal risk, whereas NTproBNP independently predicts cardiovascular risk.
引用
- Bidadkosh A, Lambooy SPH, Heerspink HJ, et al. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy. Diabetes Care. 2017. PMID: 28341782. doi:10.2337/dc16-2175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。